RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these two subtypes establishing that pCMML is RAS-pathw...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:76c77b395be34b1d8dcd36a45fbde44e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:76c77b395be34b1d8dcd36a45fbde44e2021-12-02T16:51:30ZRAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis10.1038/s41467-021-23186-w2041-1723https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23186-whttps://doaj.org/toc/2041-1723Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these two subtypes establishing that pCMML is RAS-pathway driven and that inhibiting RAS-driven PLK1 expression is a viable therapeutic target.Ryan M. CarrDenis VorobyevTerra LashoDavid L. MarksEzequiel J. TolosaAlexis VedderLuciana L. AlmadaAndrey YurchekoIsmael PadioleauBonnie AlverGiacomo ColtroMoritz BinderStephanie L. SafgrenIsaac HornXiaona YouEric SolaryMaria E. BalasisKurt BergerJames HiebertThomas WitzigAjinkya BuradkarTemeida GrafPeter ValentAbhishek A. MangaonkarKeith D. RobertsonMatthew T. HowardScott H. KaufmannChristopher PinMartin E. Fernandez-ZapicoKlaus GeisslerNathalie DroinEric PadronJing ZhangSergey NikolaevMrinal M. PatnaikNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Ryan M. Carr Denis Vorobyev Terra Lasho David L. Marks Ezequiel J. Tolosa Alexis Vedder Luciana L. Almada Andrey Yurcheko Ismael Padioleau Bonnie Alver Giacomo Coltro Moritz Binder Stephanie L. Safgren Isaac Horn Xiaona You Eric Solary Maria E. Balasis Kurt Berger James Hiebert Thomas Witzig Ajinkya Buradkar Temeida Graf Peter Valent Abhishek A. Mangaonkar Keith D. Robertson Matthew T. Howard Scott H. Kaufmann Christopher Pin Martin E. Fernandez-Zapico Klaus Geissler Nathalie Droin Eric Padron Jing Zhang Sergey Nikolaev Mrinal M. Patnaik RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
description |
Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these two subtypes establishing that pCMML is RAS-pathway driven and that inhibiting RAS-driven PLK1 expression is a viable therapeutic target. |
format |
article |
author |
Ryan M. Carr Denis Vorobyev Terra Lasho David L. Marks Ezequiel J. Tolosa Alexis Vedder Luciana L. Almada Andrey Yurcheko Ismael Padioleau Bonnie Alver Giacomo Coltro Moritz Binder Stephanie L. Safgren Isaac Horn Xiaona You Eric Solary Maria E. Balasis Kurt Berger James Hiebert Thomas Witzig Ajinkya Buradkar Temeida Graf Peter Valent Abhishek A. Mangaonkar Keith D. Robertson Matthew T. Howard Scott H. Kaufmann Christopher Pin Martin E. Fernandez-Zapico Klaus Geissler Nathalie Droin Eric Padron Jing Zhang Sergey Nikolaev Mrinal M. Patnaik |
author_facet |
Ryan M. Carr Denis Vorobyev Terra Lasho David L. Marks Ezequiel J. Tolosa Alexis Vedder Luciana L. Almada Andrey Yurcheko Ismael Padioleau Bonnie Alver Giacomo Coltro Moritz Binder Stephanie L. Safgren Isaac Horn Xiaona You Eric Solary Maria E. Balasis Kurt Berger James Hiebert Thomas Witzig Ajinkya Buradkar Temeida Graf Peter Valent Abhishek A. Mangaonkar Keith D. Robertson Matthew T. Howard Scott H. Kaufmann Christopher Pin Martin E. Fernandez-Zapico Klaus Geissler Nathalie Droin Eric Padron Jing Zhang Sergey Nikolaev Mrinal M. Patnaik |
author_sort |
Ryan M. Carr |
title |
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
title_short |
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
title_full |
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
title_fullStr |
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
title_full_unstemmed |
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
title_sort |
ras mutations drive proliferative chronic myelomonocytic leukemia via a kmt2a-plk1 axis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e |
work_keys_str_mv |
AT ryanmcarr rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT denisvorobyev rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT terralasho rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT davidlmarks rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT ezequieljtolosa rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT alexisvedder rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT lucianalalmada rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT andreyyurcheko rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT ismaelpadioleau rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT bonniealver rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT giacomocoltro rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT moritzbinder rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT stephanielsafgren rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT isaachorn rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT xiaonayou rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT ericsolary rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT mariaebalasis rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT kurtberger rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT jameshiebert rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT thomaswitzig rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT ajinkyaburadkar rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT temeidagraf rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT petervalent rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT abhishekamangaonkar rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT keithdrobertson rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT matthewthoward rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT scotthkaufmann rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT christopherpin rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT martinefernandezzapico rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT klausgeissler rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT nathaliedroin rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT ericpadron rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT jingzhang rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT sergeynikolaev rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis AT mrinalmpatnaik rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis |
_version_ |
1718382925953630208 |